- Home
- Companies
- TauroPharm GmbH
- Products
- TauroLock - Model HEP500 - Catheter ...
TauroLock - Model HEP500 - Catheter Lock Solution
In order to meet the specific needs of each patient, we have developed a range of different catheter lock solutions. With 500 IU/ml of heparin, TauroLock™-HEP500 is particularly suitable for those who want to minimise occlusion rates throughout dialysis treatment.
TauroLock™-HEP500 is to be used with a catheter-based vascular access device for hemodialysis. This type of lock solution prevents the formation of bacterial biofilms. Therefore, patients remain protected from catheter-related infections and ensure a high patency rate at the same time.
TauroLock™-HEP500 consists of three active ingredients:
- taurolidine
- heparin (500 units per ml)
- citrate (4 %)
Taurolidine has a broad antimicrobial activity (incl. MRSA and VRE) against gram-positive and gram-negative bacteria and fungi (e.g. Candida). Heparin and citrate both prevent occlusions within the catheter.
In-between treatment sessions, TauroLock™-HEP500 is instilled into the saline-flushed access system. Please note that medical staff have to check the filling volume of the respective catheter or port system.
In some cases, we do not recommend using TauroLock™-HEP500 for vascular access systems (VAD):
- The patient has been diagnosed with HIT.
- The patient has displayed a hypersensitive reaction to citrate or taurolidine.
- The patient is taking medication which interferes with either citrate, heparin, or taurolidine.
Alternatively, you may rely on TauroLock™ and/or TauroLock™-U25.000 to prevent catheter-associated complications.
Prior to the next treatment, TauroLock™-HEP500 must be aspirated.
If you would like to purchase TauroLock™-HEP500, there are two options available:
- ampoules of 5 ml (single dose, 10 ampoules per box)
- vials of 10 ml (mulitple dose, 100 vials per box)
TauroLock™-HEP500 must be stored at 15 °C to 30 °C. Please note that you must not freeze TauroLock™-HEP500 under any circumstances.